Every material Form 8-K IBEX Ltd has filed with the SEC since May 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
IBEX reported record first-quarter fiscal 2027 results for the quarter ended September 30, 2026, with revenue up 15.9% to $175.2 million and diluted EPS up 19.6% to $0.99. The company raised its full-year fiscal 2027 revenue and adjusted EBITDA guidance, which signals management expects stronger results for the year.
Revenue $175.2 million, up 15.9% from $151.2 million; net income $14.8 million versus $12.0 million
Diluted EPS $0.99 versus $0.82; adjusted diluted EPS $1.10 versus $0.90
Revenue guidance raised to $720 million to $735 million from $700 million to $715 million
Adjusted EBITDA guidance raised to $96 million to $99 million from $90 million to $94 million
IBEX reported fiscal 2026 results for the year ended June 30, 2026, with full-year revenue up 15.4% to $644.1 million and diluted EPS up 32.8% to $3.13. Fourth-quarter revenue rose 11.6%, but net income fell 8.8% to $8.7 million and diluted EPS fell 11.3% to $0.59. The company also introduced fiscal 2027 guidance and amended its U.S. and UAE credit facilities, extending maturities to October 22, 2029.
Fiscal 2026 revenue $644.1 million, up 15.4%; diluted EPS $3.13 versus $2.36 a year earlier
Fourth-quarter net income $8.7 million versus $9.6 million; net income margin 5.3% versus 6.5%
Fiscal 2027 revenue guidance $700 million to $715 million; adjusted EBITDA guidance $90 million to $94 million
U.S. credit facility of $25 million and UAE facilities amended on September 8, 2026, with maturity extended to October 22, 2029
IBEX Limited's board authorized a share repurchase program of up to $20 million of common stock over one year, starting May 14, 2026. The company says it will fund repurchases from existing cash and free cash flow, but it is not obligated to buy any set amount and can suspend or end the program at any time.
Board approved the program on May 11, 2026; repurchases can begin May 14, 2026.
Authorization covers up to $20 million of common stock over one year.
Repurchases may be made in open market or private transactions, subject to Rule 10b-18 and Rule 10b5-1.
The company may suspend or discontinue the program at any time.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every IBEX Ltd filing is on SEC EDGAR ↗. 8-K briefs of other companies →